维普期刊资源整合服务平台（V6.5）

47篇 您的检索式：作者名="STAL O"

选中清除导出查看参考文献查看引证文献引用追踪共3页首页上一页第1页下一页末页 /3 跳转

	题名	作者	年代	出处	被引量
1	p53polymorphic variants at codon72and the outcome of therapy in ran-domized breast cancer patients显示文摘	Wegman P Stal O Askmalm MS	2006	Pharmacogenet Ge-nomics2006，16，5：	1
2	Microstructure of model cermets with high Mo or W content显示文摘	LINDAHL P GUSTAFSON P ROLANDER U STALS L ANDREN H O	1999	International Journal of Refractory Metals & Hard Materials1999，17，6：	1
3	p53 expression and the result of adjuvant therapy of breast cancer显示文摘	Stal O Stenmark AM Wingren S	1995	Acta Oncol1995，34，6：	1
4	Activat-ion of AKT/PKB in breast cancer predicts a worse outcome among endocrine treated patients显示文摘	Perez-Tenorio G Stal O Southeast Sweden Breast Cancer Group	2002	Br J Cancer2002，86，4：	1
5	Overexpression of MDM2 in acute childhood lymphoblastic leukemia显示文摘	Gustafsson B Stal O Gustafsson B	1998	Pediatr Hematol Oncol1998，15，6：	1
6	C-erbB-2 overexpression and survival in early onset breast cancer显示文摘	Agrup M Stal O Olsen K	2000	Breast Cancer Res Treat2000，63，1：	1
7	p53 polymorphic variants at codon 72 and the outcome of therapy in randomized breast can- cer patients显示文摘	Wegman P Stal O Askmalm MS	2006	Pharmacogenet Genomics2006，16，5：	1
8	Abnormal expression of 17beta- hydroxysteroid dehydrogenases in breast cancer predicts late recurrence 显示文摘	Gunnarsson C Olsson BM Stal O	2001	Cancer Res2001，61，23：	1
9	Genotype of metabolic enzymes and the benefit of tamoxifen in postmenopausal breast cancer patients 显示文摘	Wegman P Vainikka L Stal O	2005	Breast Cancer Res2005，7，：	1
10	C-erbB- 2 overexpression and survival in early onset breast cancer显示文摘	AGRUP M STAL O OLSEN K	2000	Breast Cancer Res Treat2000，63，1：	1
11	Akt kinases in breast cancer and the results of adjuvant therapy显示文摘	STAL O PEREZ-TENORIO G AKERBERG L	2003	Breast Cancer Res2003，5，2：	1
12	Genotype of metabolic enzymes and the benefit oftamoxifen in postmenopansal breast cancer patients显示文摘	Wegrnan P Vainikka L Stal O	2005	Breast Cancer Res2005，7，3：	1
13	Activation of AKT/PKB in breast cancer predicts a worse outcome among endocrine treated patients 显示文摘	PEREZ-TENORIO G STAL O Southeast Sweden Breast Cancer Group	2002	BrJ Cancer2002，86，4：	1
14	Activation of AKT/PKB in breast cancer predicts a worse outcome among endocrine treated patients显示文摘	Perez-Tenorio G Stal O	2002	Br J Cancer2002，86，：	1
15	C-erbB-2 overexpression and survival in early onset breast cancer显示文摘	Agrup A Stal O Olsen K	2000	Breast Cancer Res Treat2000，63，1：	1
16	C-erbB-2 overexpression and survival in early onset breast cancer显示文摘	Agrup M Stal O Olsen K	2000	Breast Cancer Res Treat2000，63，1：	1
17	HER-2 status in hormone receptor positive premenopausal primary breast cancer adds prognostic,but not tamoxifen treatment predictive,information显示文摘	Ryden L Landberg G Stal O	2008	Breast Cancer Res Treat2008，109，2：	1
18	ErbB2 status and the benefit from two or five years of adjuvant tamoxifen in postmenopausal early stage breast cancer 显示文摘	STAL O BORG A FERNO M	2000	Ann Oncol2000，11，12：	1
19	C-erbB-2 overexpression and survival in early onset breast eaneer 显示文摘	Agrup M Stal O Olsen K	2000	Breast Cancer Res Treat2000，63，：	1
20	Activation of AKT/PKB in breast cancer predicts a worse outcome among endocrine treated patients显示文摘	Perez-Tenorio G Stal O Southeast Sweden Breast Cancer Group	2002	Br J Cancer2002，86，4：	1

返回顶部每页显示：

共3页首页上一页第1页下一页末页 /3 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示